Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil  by Lanzieri, Tatiana M. et al.
International Journal of Infectious Diseases 15 (2011) e206–e210Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil
Tatiana M. Lanzieri a,*, Alexandre C. Linhares b, Iolanda Costa c, Devayani A. Kolhe d,
Maria Helena Cunha c, Eduardo Ortega-Barria a, Romulo E. Colindres a
aGlaxoSmithKline Biologicals, Estrada dos Bandeirantes, 8464, Rio de Janeiro 22783-110, Brazil
b Instituto Evandro Chagas, Secretaria de Vigilaˆncia em Sau´de, Ministe´rio da Sau´de, Bele´m, Para´, Brazil
c Secretaria de Estado de Sau´de do Estado do Para´, Bele´m, Brazil
dGlaxoSmithKline Biologicals, Bangalore, India
A R T I C L E I N F O
Article history:
Received 11 August 2010
Received in revised form 26 October 2010
Accepted 17 November 2010
Keywords:
Gastroenteritis
Rotavirus
Mortality
Human rotavirus vaccine
Brazil
S U M M A R Y
Objectives: Rotavirus vaccination was introduced in Brazil in March 2006, targeting an annual birth
cohort of approximately 3.5 million. We analyzed trends in all-cause gastroenteritis-related deaths in
children <5 years of age during the pre- and post-vaccination periods.
Methods: Data from the National Immunization Program and the Mortality Information System were
used to calculate vaccine coverage and mortality rates related to gastroenteritis in children <1 year and
1–4 years of age, using population estimates from the census as the denominator. Relative reductions in
mortality rates were calculated for 2007 and 2008, using the 2004–2005mean as baseline before vaccine
introduction.
Results: Coverage of two doses of human rotavirus vaccine was 39% in 2006, increasing to 72% in 2007
and 77% in 2008. During 2004–2005, the gastroenteritis mortality rate in children <1 year of age was
56.9 per 100 000, decreasing by 30% (95% conﬁdence interval (CI) 19–41) in 2007 and by 39% (95% CI 29–
49) in 2008. In children 1–4 years of age, the mortality rate was 4.5 per 100 000 during 2004–2005,
decreasing by 29% (95% CI 10–49) in 2007 and by 33% (95% CI 15–52) in 2008.
Conclusions: The decreased rates of childhood gastroenteritis-related deaths in Brazil following
rotavirus vaccine introduction, particularly among children<1 year of age, suggest the potential beneﬁt
of vaccination.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Rotavirus infection remains the most common cause of severe,
dehydrating gastroenteritis among children worldwide. Almost
every child in the world, in both developed and developing
countries, will be infected with rotavirus in the ﬁrst 5 years of life.
Approximately 611 000 childhood deaths annually are caused by
rotavirus, most of them in developing countries.1 Since only non-
speciﬁc symptomatic therapies are available, prevention by
vaccination is considered to be critical for effective control of
rotavirus infection and may have a signiﬁcant impact on the
incidence of severe dehydrating rotavirus disease.1
With the widespread use of oral rehydration therapy strategies,
deaths from diarrhea have declined substantially in the developing
world. Diarrhea morbidity has not had a concomitant decrease,
with an estimated 3–5 billion cases of diarrhea occurring
worldwide each year, mostly among children.2,3 In Brazil, declining
trends in gastroenteritis-related mortality associated with the* Corresponding author. Tel.: +1 404 399 8529.
E-mail address: tatiana.m.lanzieri@gmail.com (T.M. Lanzieri).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.11.007increased use of oral rehydration therapy were observed in the
1980s and 1990s.4 Nonetheless, diarrhea remains an important
cause of childhood morbidity and mortality, with rotavirus
infections estimated to cause approximately 3.5 million diarrhea
episodes, 655 853 outpatient visits, 92 453 hospitalizations, and
850 deaths each year in children aged 5 years, before vaccine
introduction.5
Brazil was one of the ﬁrst Latin American countries to include
the human rotavirus vaccine into the expanded program on
immunization in March 2006. A marked decline in the number of
all-cause gastroenteritis hospitalizations among children aged <1
year was observed one year after vaccine introduction.6–8 In this
study, we analyzed the trends in all-cause gastroenteritis-related
mortality among children aged <5 years in Brazil before and after
implementation of rotavirus vaccination.
2. Methods
2.1. Vaccine coverage
The number of ﬁrst and second doses of rotavirus vaccine
administered are recorded at the local level by primary health careses. Published by Elsevier Ltd. All rights reserved.
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Fig. 1. Trends over time of gastroenteritis-related deaths by age group, Brazil, 1998–
2008.
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database at the municipal level and transmitted electronically
to the state and national level. The numbers for both the ﬁrst
and second doses and vaccine coverage are available at the
National Uniﬁed Health System Database (DATASUS) website
and data can be tabulated by municipality, state, region, and
year. From the year 2000, the National Immunization Program
started using the number of live births as recorded in the Live
Birth Information System (SINASC) for vaccine coverage
calculations. Whereas the coverage of SINASC has increased
from 75% (range 55–102) in 1994 to 92% (range 84–100) in 2006,
underreporting of live births still occurs, with the lowest
coverage in the Northeast region.9 In addition, SINASC data used
as the denominator for vaccine coverage calculations are
generally from the birth cohort of the two previous years. In
this study, we chose to use the census estimates for the
population aged <1 year and 1–4 years to calculate rotavirus
vaccine coverage for the ﬁrst and second dose from 2006 to
2008, to estimate the cumulative proportion of children who
had received rotavirus vaccination each year.
2.2. Mortality data
The Brazilian Ministry of Health is responsible for maintaining
mortality data based on death certiﬁcates. The Mortality Informa-
tion System (Sistema de Informac¸a˜o de Mortalidade – SIM)
contains data for primary cause of death obtained from death
certiﬁcates, and using the International Classiﬁcation of Diseases
(ICD), 10th Revision (since 1998). Data collected from death
certiﬁcates are recorded and analyzed for consistency at the
municipal level, transmitted electronically to the state and
national level, and made available for direct tabulation on the
DATASUS website. Annual databases usually take up to two years
to be ﬁnalized. The coverage of the SIM is calculated based on the
number of observed deaths (reported to the system) divided by the
number of expected deaths (based on census projections) for all
ages and for the age group <1 year. From 1991 to 2006, the
coverage increased from 78% to 89% overall and from 56% to 72% in
the age group <1 year. By 2006, the coverage had increased in all
regions, reaching 85%, except the Northeast region, where only
54% of expected deaths in children <1 year were reported.9
We obtained data on all-cause gastroenteritis-related deaths
among children <5 years of age during 1998–2008 from the
Mortality Information System using the codes A00 to A09 of the
ICD 10th Revision. Annual rates of all-cause gastroenteritis-related
mortality were calculated using the population estimates from the
census as a denominator. The mean rate of all-cause gastroenteri-
tis-related mortality during 2004–2005 was used as baseline to
compare with post-vaccination years 2007 and 2008. This baseline
period was chosen because a declining trend was already in
evidence for the past decades and would artiﬁcially increase the
presumed impact of vaccination. We considered 2006 a transi-
tional year and excluded it from the analysis because vaccination
was introduced during this year and coverage was suboptimal.
Analysis was stratiﬁed according to age groups <1 year and 1–4
years and by region. The absolute and relative reduction in deaths
and mortality rate were calculated, with 95% conﬁdence inter-
vals.10 Analysis was performed using SAS statistical software,
version 9.1 and Microsoft Excel.
3. Results
3.1. Vaccine coverage
From March 2006 to December 2008, more than 13.5 million
doses of human rotavirus vaccine were administered to children<1 year of age, 56% as ﬁrst doses and 44% as second doses.
Coverage of one dose of human rotavirus vaccine was 60% in
2006, 85% in 2007, and 90% in 2008. Lower vaccine coverage was
observed for the second dose: 39% in 2006, 72% in 2007, and 77%
in 2008. In 2008, an estimated 38% of the population 1–4 years
of age had received one vaccine dose, with 28% having received
two doses. Vaccine coverage varied by region, being highest in
the South and Southeast regions, where the coverage of the
second dose reached 88% and 84% in 2008, respectively, and
remained the lowest in the North (66%) and Northeast (69%)
regions. All regions achieved over 80% vaccine coverage for the
ﬁrst dose in 2008.
3.2. All-cause gastroenteritis-related mortality
Of 33 363 gastroenteritis-related deaths among children <5
years of age reported in Brazil during 1998–2008, 27 375 (82%)
were in children <1 year of age. This age group has seen a marked
decline in the number and rates of gastroenteritis-related deaths
over the past decade (Fig. 1).
During 2004–2005, considered the baseline period before
vaccine introduction, the mean number of gastroenteritis-related
deaths observed in children<1 yearwas 1994 and in those aged 1–
4 years was 516, of which 1185 (59%) and 231 (45%), respectively,
occurred in the Northeast region. A reduction in the number of
gastroenteritis-related deaths in children <1 year of age was
observed in all regions in 2007 and 2008 (Fig. 2), by 36% (range 27–
55) and 45% (range 37–64), respectively. The highest reduction rate
in children <1 year of age was observed in the South region (54%)
in 2008, whereas the absolute number of gastroenteritis-related
deaths in the Northeast region fell from a mean of 1185 during
2004–2005 to 751 (by 37%) in 2007 and 661 (by 44%) in 2008. In
children 1–4 years of age, gastroenteritis-related deaths decreased
by 28% (range 15–48) in 2007 and by 34% (range 0–48) in 2008,
with the highest reduction rates observed in the North and Mid-
West regions.
The gastroenteritis-related mortality rate in children aged <1
year fell from a mean of 56.9 per 100 000 during 2004–2005, to
39.6 in 2007 and 35.0 in 2008, representing relative reductions of
30% (95% conﬁdence interval (CI) 19–41) and 39% (95% CI 29–49),
respectively. The highest mortality rates were observed in the
Northeast region, with a mean of 112.4 per 100 000 during 2004–
2005, decreasing by 35% (95% CI 29–41) in 2007 and by 42% (95% CI
37–48) in 2008 (Table 1). In children aged 1–4 years, the
gastroenteritis mortality was 4.5 per 100 000 during 2004–
2005, decreasing by 29% (95% CI 10–49) in 2007 and by 33% (95% CI
15–52) in 2008. The relative reduction in this age group was
signiﬁcant in both years only in the North and Mid-West regions
(Table 1).
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Fig. 2.Number of gastroenteritis deaths by region among children<1 and 1–4 years
of age in 2007 and 2008 compared to the 2004–2005 baseline period, Brazil.
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Brazil introduced the human rotavirus vaccine into the
childhood schedule in 2006 and uptake of the vaccine has
increased over time. Although this was an ecological study andTable 1
Changes in childhood gastroenteritis-related mortality rates (per 100 000) in Brazil in 2
group.
Age group Region 2004–2005 mean mortality ratea 2007
Mortality r
<1 year North 82.1 65.4
Northeast 112.4 73.4
Southeast 22.6 14.7
South 22.3 12.4
Mid-West 45.2 32.1
All 56.9 39.6
1–4 years North 8.6 5.7
Northeast 5.4 4.7
Southeast 1.4 1.0
South 1.3 0.8
Mid-West 5.8 3.8
All 4.5 3.2
CI, conﬁdence interval.
a Baseline values are the mean gastroenteritis-related mortality rates for 2004–2005decreasing mortality trends have been in evidence over the past
decades, the introduction of rotavirus vaccination has likely
contributed to the observed reduction in both absolute numbers
and rates of mortality related to childhood gastroenteritis,
particularly in children <1 year of age, in whom the highest
mortality rates due to diarrheal diseases have been observed for
the past decade.
In Brazil, the mortality rate from all-cause gastroenteritis in
children <1 year of age nationwide decreased by 30–39% during
2007–2008 relative to 2004–2005,whereas themortality rate from
lower respiratory tract infections in children <1 year of age
decreased by 12–16% in the same period.11 The Brazilian Family
Health Program has been successful in reducing childhood
mortality, particularly due to diarrheal diseases and lower
respiratory infections, through promotion of breastfeeding,
immunization, and the prevention and treatment of infectious
diseases. The strongest reductions in mortality due to diarrhea
have been observed in municipalities with higher coverage of the
Family Health Program during 2000–2005.12 The continued
expansion of such programs, reaching nearly half of the Brazilian
population by 2007–2008,13 together with the increased coverage
of thewater supply and sewage systems and the overall increase in
education level in the population >15 years of age,9 have had an
important impact on childhood mortality rates, particularly due to
infectious diseases and diarrhea. Nonetheless, the strongest
reductions in mortality rates due to gastroenteritis in the South
and Southeast regions, with the highest rotavirus vaccine coverage,
also suggest the beneﬁt of vaccination.
The gastroenteritis mortality rates in Brazil have varied greatly
by region, being highest in the North and Northeast, which are the
most impoverished regions in the country. The rates observed in
the Northeast regionwere up to ﬁve times the rates observed in the
South and Southeast regions. Several studies have indicated the
importance of diarrheal diseases as a public health problem in the
Northeast and the beneﬁt of other health interventions in the last
decades in reducing related deaths, such as the increased use of
oral rehydration therapy, increased breastfeeding duration, better
nutrition, improved water supply, hygiene and sanitation, and the
implementation of the Family Health Program.4,14,15 Nonetheless,
the burden of diarrheal diseases remains high in the region and is
likely underestimated, since access to health care may be limited
and nearly half of the expected deaths in children <1 year of age
may not have been reported according to 2008 estimates.9,16
Other studies in the state of Sergipe, Northeast Brazil, have
shown important reductions in the burden of rotavirus and non-
rotavirus diarrhea, as well as consultations and hospitalizations
due to all-cause diarrhea, post-vaccine introduction.7,8,17 On the007 and 2008, compared with the baseline period (2004–2005), by region and age
2008
ate % Reduction (95% CI) Mortality rate % Reduction (95% CI)
20 (6–34) 59.2 28 (15–41)
35 (29–41) 64.9 42 (37–48)
35 (23–47) 12.8 44 (32–55)
44 (25–63) 10.3 54 (36–71)
29 (8–50) 27.2 40 (21–58)
30 (19–41) 34.9 39 (29–49)
34 (15–53) 5.1 40 (23–58)
12 (5–29) 4.0 25 (10–40)
31 (6–56) 1.1 23 (4–50)
40 (0–80) 1.6 22 (89–46)
35 (9–62) 3.2 45 (21–69)
29 (10–49) 3.00 33 (15–52)
.
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were not offset by the decrease in the number of cases of diarrhea
andhospitalizations.17Nonetheless, deathswerenot included in the
analyses, the burden of rotavirus disease could not be expressed in
terms of DALYs (disease-adjusted life years), and a longer period of
analysis may be needed to demonstrate a new health intervention
becoming cost-saving. We observed a reduction in the rates of
childhood death from gastroenteritis in children <1 year of age in
2007 and 2008, representing a substantial decrease in the absolute
numbers of deaths, particularly in the Northeast region.
Of note, signiﬁcant reductions in mortality rates from all-cause
gastroenteritis were observed among children aged 1–4 years in
Brazil nationwide and in the North and Mid-West regions. The
cumulative proportion of children 1–4 years of age vaccinatedwith
either one or two doses in this age group was still low in 2008,
suggesting factors other than vaccination may have played a role.
Nonetheless, indirect effects on non-vaccinated individuals
through reduced viral transmission in the community (e.g., herd
immunity) also needs to be further investigated. In the USA, the
reduction in hospitalization rates for acute gastroenteritis noted
among age groups too young or too old to be vaccinated with the
pentavalent rotavirus vaccine, and the change in the seasonal
pattern of rotavirus, with a delayed season onset and peak in 2008,
raised the possibility of herd immunity.18 In Sao Paulo, Southeast
Brazil, the onset of rotavirus activity in the 2007 and in 2008
seasons also appeared to have been delayed when compared with
the prevaccine rotavirus seasons, and an overall reduction in
hospitalizations for all-cause gastroenteritis among children <5
years of age (29%), as well as in the number of rotavirus-speciﬁc
acute gastroenteritis cases in children 3–5 years of age (29%), an
age group too old to be vaccinated, were also observed after the
introduction of the human rotavirus vaccine.7
A hospital-based surveillance study conducted in Brazil during
2005–2006 has found that the percentage of samples positive for
rotaviruswas43% inchildrenhospitalizedwithacute gastroenteritis
and/or requiring rehydration therapy. This proportion varied from
21% in the South to 53% in the Southeast region.19 A recent meta-
analysis of studies conducted in Latin America and the Caribbean,
estimated that the proportion of diarrhea due to rotavirus in
inpatients in Brazil is 25.7% (95% CI 20.7–30.9).20 The effectiveness
against very severe rotavirus infection might best reﬂect effective-
ness against the fraction of diarrhea deaths attributable to rotavirus,
and was estimated to be 74% in a recent review, suggesting that a
rotavirus vaccination program has the potential to substantially
reduce child mortality in low-income countries if appropriately
implemented.21 Later studies conducted in the Northeast andNorth
regions in Brazil have estimated 76% to 95% effectiveness of the
human rotavirus vaccine in preventing severe rotavirus gastroen-
teritis hospitalizations, predominantly due to G2P[4].8,22,23
We have observed an increase in the uptake of vaccine over
time, with more than 80% of children having had at least one dose
of rotavirus vaccine in 2008, demonstrating a successful integra-
tion of the human rotavirus vaccine into the national immuniza-
tion program. However, the coverage of the second dose remains
suboptimal in the Northeast and North regions, where the highest
burden of all-cause gastroenteritis resulting in childhood deaths is
observed. Therefore, increasing vaccine coverage should lead to the
greatest impact on preventing childhood deaths.
The reduction in mortality rates due to all-cause gastroenteritis
in children<1 year of age in Brazil was comparable to that observed
in Mexico in 2008 following rotavirus vaccine introduction during
2006–2007.24The resultsof this studyarealso in linewithaprevious
study reporting a decrease in hospitalizations due to all-cause
gastroenteritis in children <1 year of age,6,7 suggesting a potential
beneﬁt of vaccination. Nonetheless, our ﬁndings need to be
interpreted with caution since this was an ecological study anddecreasing trends in childhood diarrhea deaths and mortality were
already inevidencebefore vaccine introduction.Other interventions
that have contributed to the decrease in gastroenteritis-associated
mortality in the past decades (oral rehydration therapy, breastfeed-
ing, nutrition, water supply, hygiene and sanitation, and the Family
Health Program) were not considered in the analysis. To counter-
balance this fact, we used as baseline a short period of two years
before vaccine introduction, when mortality seemed to have
reached a steady state. We were unable to evaluate the reduction
in mortality rates during rotavirus season months in regions with
marked seasonality of rotavirus disease (South and Southeast
regions), sincemonthlydistributionofdeaths is not readily available
from theDATASUSwebsite. The use of the administrativemethod to
calculate vaccine coverage has the advantage of providing national
estimates readily available to monitor program implementation,
however, somepopulation-based surveyshave indicated that itmay
overestimate vaccine coverage and does not consider inequalities
regarding access to health care and vaccination.25,26 Other limita-
tions are related to the reliability of data, as for the ascertainment of
cause of death and underreporting, as well as for the population
estimates used as the denominator. Deaths from diarrhea affecting
thepoorest familiesmaybe reported less often thanother childhood
deaths, despite the increasing trend in reporting infant deaths.With
falling fertility rates, the population <1 year of age may be
overestimated by the census,9 thus yielding an underestimation
of vaccine coverage and childhood mortality rates.
This study highlights the potential impact of the introduction of
rotavirus vaccine in preventing deaths from gastroenteritis in
Brazil. An additional 14 countries in Latin America have already
included the vaccine in their immunization programs. Access to
vaccine and impact of vaccination might differ among countries.
Complementing studies designed to directly measure vaccine
effectiveness, secondary databases can be useful tools for
continuous monitoring and documentation of vaccine coverage
and the effect of vaccination on childhoodmorbidity andmortality.
Additionally, regression models including smaller analysis units
(e.g., municipalities) exploring themultiple factorswith a potential
effect on childhood deaths from diarrhea, as well as mathematical
transmission models using different vaccine coverage levels, may
be useful to estimate the direct and indirect effect of vaccination
following introduction.
Conﬂict of interest
ACL, IC, and MHC were funded through their institutions by
GlaxoSmithKline Biologicals to carry out the study protocol. DAK,
EOBandRECare employeesofGlaxoSmithKlineBiologicals. TMLwas
employed by GlaxoSmithKline Biologicals at the time of this study.
Role of funding source
Study sponsors were involved in the study design, in the
analysis and interpretation of data, in the writing of the
manuscript, and in the decision to submit the manuscript for
publication.
Ethical approval
The study protocol has been submitted, reviewed, and approved
by the Ethics Committee of Instituto Evandro Chagas.
Acknowledgements
This study was sponsored by GlaxoSmithKline Biologicals. We
thank the GlaxoSmithKline Biologicals Brazil team, led by Nervo
Sanchez.
T.M. Lanzieri et al. / International Journal of Infectious Diseases 15 (2011) e206–e210e210References
1. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood
diarrhea. Emerg Infect Dis 2006;12:304–6.
2. Guerrant RL, Carneiro-Filho BA, Dillingham RA. Cholera, diarrhea, and oral
rehydration therapy: triumph and indictment. Clin Infect Dis 2003;37:398–405.
3. Hotez PJ, Remme JH, Buss P, et al. Combating tropical infectious diseases: report
of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis
2004;38:871–8.
4. Victora CG, Olinto MT, Barros FC, Nobre LC. Falling diarrhoea mortality in
Northeastern Brazil: did ORT play a role? Health Policy Plan 1996;11:132–41.
5. Sartori AM, Valentim J, de Soa´rez PC, Novaes HM. Rotavirus morbidity and
mortality in children in Brazil. Rev Panam Salud Publica 2008;23:92–100.
6. Lanzieri TM, Costa I, Shaﬁ AF, Cunha MH, Ortega-Barria E, Linhares AC, et al.
Trends in hospitalizations from all-cause gastroenteritis in children<5 years of
age in Brazil before and after human rotavirus vaccine introduction, 1998-2007.
Pediatr Infect Dis J 2010;29:673–5.
7. Sa´fadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, et al.
Hospital-based surveillance to evaluate the impact of rotavirus vaccination in
Sa˜o Paulo, Brazil. Pediatr Infect Dis J 2010 [Epub ahead of print].
8. Gurgel RG, Bohland AK, Vieira SC, Oliveira DM, Fontes PB, Barros VF, et al.
Incidence of rotavirus and all-cause diarrhea in Northeast Brazil following the
introduction of a national vaccination program. Gastroenterol 2009;137:1970–5.
9. Rede Interagencial de Informac¸o˜es para a Sau´de. Indicadores e dados ba´sicos,
Brasil–indicadores de cobertura. [Interagency Net of Health Information. Basic
indicators and data, Brazil–coverage indicators]. Available at: http://tabnet.da-
tasus.gov.br/cgi/idb2008/matriz.htm (accessed April 1, 2010).
10. Hildebrandt M, Bender R, Gehrmann U, Blettner M. Calculating conﬁdence
intervals for impact numbers. BMC Med Res Methodol 2006;6:32.
11. Ministerio da Sau´de, Secretaria de Vigilancia em Sau´de, Departamento de
Ana´lise da Situac¸a˜o de Sau´de. Sistema de Informac¸o˜es sobre Mortalidade
[Ministry of Health, Secretariat of Health Surveillance, Department for the
Analysis of the Health Situation. Mortality Information System]. Available at:
http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sim/cnv/obtuf.def (accessed
October 1, 2010).
12. Rasella D, Aquino R, Barreto ML. Reducing childhood mortality from diarrhea
and lower respiratory tract infections in Brazil. Pediatrics 2010;126:e534–40.
13. Ministerio da Sau´de, Secretaria de Atenc¸a˜o a` Sau´de, Departamento da Atenc¸a˜o
Ba´sica. Sau´de da Famı´lia [Ministry of Health, Secretariat of Health Assistance,
Department of Basic Assistance. Family Health]. Available at: http://
200.214.130.35/dab/abnumeros.php (accessed October 1, 2010).14. Fac¸anha MC, Pinheiro AC. Acute diarrhea treated by health care services in
Fortaleza, Ceara´ State, Brazil, from1996 to 2001. Cad Sau´de Pu´blica 2005;21:49–
54.
15. Vasconcelos MJ, Bastista Filho M. Diarrheal disease in children under ﬁve years
of age in the State of Pernambuco, Brazil: prevalence and utilization of health
services. Rev Bras Epidemiol 2008;11:128–38.
16. Frias PG, Pereira PM, Andrade CL, Szwarcwald CL. Sistema de Informac¸o˜es sobre
Mortalidade: estudo de caso em municı´pios com precariedade dos dados. Cad
Sau´de Pu´blica 2008;24:2257–66.
17. Centenari C, Gurgel RQ, Bohland AK, Oliveira DM, Faraguer B, Cuevas LE.
Rotavirus vaccination in northeast Brazil: a laudable intervention, but can it
lead to cost-savings? Vaccine 2010 Apr 23 [Epub ahead of print].
18. Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in
acute gastroenteritis hospitalizations among US children after introduction of
rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect
Dis 2010;201:1617–24.
19. Munford V, Gilio AE, de Souza EC, Cardoso DM, Cardoso DD, Borges AM, et al.
Rotavirus gastroenteritis in children in 4 regions in Brazil: a hospital-based
surveillance study. J Infect Dis 2009;200(Suppl 1):S106–13.
20. Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, et al.
Burden and circulating strains of rotavirus infection in Latin America and the
Caribbean: systematic review and meta-analysis.. Poster presented at the 9th
International Rotavirus Symposium. 2010.
21. Munos MK, Walker CL, Black RE. The effect of rotavirus vaccine on diarrhea
mortality. Int J Epidemiol 2010;39:56–62.
22. JustinoMC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, et al.
Effectiveness of the Monovalent G1P[8] Human Rotavirus Vaccine Against
Hospitalization for Severe G2P[4] Rotavirus Gastroenteritis in Bele´m, Brazil.
Pediatr Infect Dis J 2010 Dec 9 [Epub ahead of print].
23. Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB,
et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe
diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis
2010;201:363–9.
24. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguillar M,
Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death
from childhood diarrhea in Mexico. N Engl J Med 2010;362:299–305.
25. Waldman EA, Mesa-Redonda:. Desigualdades sociais e cobertura vacinal: uso
de inque´ritos domiciliares. Rev Bras Epidemiol 2008;11(Suppl 1):129–32.
26. Moraes JC, Barata RB, Ribeiro MC, Castro PC. Cobertura vacinal no primeiro ano
de vida em quatro cidades do estado de Sa˜o Paulo, Brasil. [Vaccination coverage
in the ﬁrst year of life in 4 cities of the state of Sa˜o Paulo, Brazil.]. Rev Panam
Salud Publica 2000;8:332–41.
